ArticleGastro hep advances2026
Registered Sick Leave in Celiac Disease: A Register-Based Nationwide Cohort Study.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The vagueness of symptoms and differences in severity in celiac disease (CeD) make it challenging to fully grasp CeD and its burden. Sick leave may be an indicator of disease burden. We aimed to assess registered sick leave before and after diagnosis of CeD in a longitudinal nationwide register-based cohort study. Methods: All patients diagnosed with CeD between 2008 and 2017 and aged 25-60 were identified in the National Patient Register. A 1:10 matching method by age and sex was used to identify a comparison cohort without CeD. Information on registered sick leave and disability pension was obtained from the Danish Register for Evaluation of Marginalization Registry. Sick leave and disability pension were assessed on a weekly basis both by proportions and by mean weeks of annual leave. Results: A total of 2494 patients with CeD and 24,578 individuals without CeD were identified. We found higher proportions and mean weeks of sick leave among patients with CeD compared with individuals without CeD from 5 years before diagnosis until 5 years after, peaking in risk ratios (RRs) 2 years after diagnosis (RR: 1.58), and in disability pension 5 years after diagnosis (RR: 1.44). The relative difference in mean number of weeks of sick leave per year was highest in the year following diagnosis (mean weeks among patients with CeD 5.80, ratio of means 1.62). Conclusion: We found increased levels of sick leave and disability pension among patients with CeD both 5 years before and 5 years after diagnosis. Measures to prevent the burden of CeD should be considered and explored further.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.